Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.

NCT02969174 | Unknown

• 1 other identifier: ShangjiTongjiHsxk
• Study Type: expanded_access
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

To establish a genotyping and extraction technology of non invasive prenatal diagnosis for fetal blood group genotype from cell-free fetal DNA in peripheral blood of pregnant women. To achieve prenatal accurate identification of fetal blood group genotypes，and provide credible theoretical evidence for the prenatal diagnosis and treatment of hemolytic disease of newborn (HDN).

Conditions

HDFN

Interventions

zimin Lu,Guo Sa OTHER

chengzhong Liu

Eligibility Criteria

• Age: 12 Weeks - 38 Weeks
• Sex: all
• Age Groups: Child (0-17)

You may qualify if:

• blood samples of pregnant couples,gender/nation/region is unlimited.

You may not qualify if:

• adipose or hemolytic samples,overdue samples,unidentified samples

Sponsors & Collaborators

• Shanghai Tongji Hospital, Tongji University School of Medicine: lead

Study Design

• Study Type: expanded access
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: The President of Shanghai Tongji Hospital

Study Record Dates

• First Submitted: November 3, 2016
• First Posted: November 21, 2016
• Last Updated: November 21, 2016

Record last verified: 2016-11